For additional information or to register online, contact: https://ccehs.upmc.com February 13–15, 2016 Eleventh International Symposium on Regional Cancer Therapies Sheraton Wild Horse Pass Resort & Spa Chandler, Arizona Sponsored by David C. Koch Regional Cancer Therapy Center and University of Pittsburgh School of Medicine Center for Continuing Education in the Health Sciences and UPMC Cancer Centers In Collaboration with The University of Maryland Marlene and Stewart Greenebaum Cancer Center and The Medical College of Wisconsin Cancer Center Course Co-Directors H. Richard Alexander, MD Professor of Surgery University of Maryland Medical Center Baltimore, Maryland David L. Bartlett, MD Professor of Surgery University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania Robert P. Edwards, MD Professor, Obstetrics and Gynecology and Reproductive Services University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania T. Clark Gamblin, MD, MS Stuart D. Wilson Chair in Surgical Oncology Chief, Division of Surgical Oncology Associate Professor of Surgery Medical College of Wisconsin Milwaukee, Wisconsin David C. Koch Regional Cancer Therapy Center UPMC Cancer Pavilion, Suite 413 5150 Centre Avenue Pittsburgh, PA 15232 Nonprofit Org. U.S. Postage PAID Pittsburgh, PA Permit No. 3834 Eleventh International Symposium on Regional Cancer Therapies Sheraton Wild Horse Pass Resort & Spa – Chandler, Arizona February 13–15, 2016
10
Embed
Eleventh International Symposium on Regional Cancer … · Eleventh International Symposium on Regional Cancer ... Stuart D. Wilson ... //ccehs.upmc.comEleventh International Symposium
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
For
addi
tion
al in
form
atio
n or
to r
egis
ter
onlin
e, c
onta
ct:
htt
ps:
//cc
ehs.
up
mc.
com
F e b r u a r y 1 3 – 1 5 , 2 0 1 6
Eleventh International Symposium on
Regional Cancer TherapiesSheraton Wild Horse Pass Resort & Spa
Chandler, Arizona
Sponsored by
David C. Koch
Regional Cancer Therapy Center
and
University of Pittsburgh School of Medicine
Center for Continuing Education
in the Health Sciences
and
UPMC Cancer Centers
In Collaboration with
The University of Maryland
Marlene and Stewart Greenebaum
Cancer Center
and
The Medical College of Wisconsin
Cancer Center
Course Co-Directors
H. Richard Alexander, MD
Professor of Surgery
University of Maryland Medical Center
Baltimore, Maryland
David L. Bartlett, MD
Professor of Surgery
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Robert P. Edwards, MD
Professor, Obstetrics and Gynecology and
Reproductive Services
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
T. Clark Gamblin, MD, MS
Stuart D. Wilson Chair in Surgical Oncology
Chief, Division of Surgical Oncology
Associate Professor of Surgery
Medical College of Wisconsin
Milwaukee, WisconsinDavid
C. K
och
Regi
onal
Canc
er T
hera
py C
ente
r
UPM
C Ca
ncer
Pav
ilion,
Sui
te 4
13
5150
Cen
tre A
venu
e
Pitts
burg
h, P
A 15
232
Nonp
rofit
Org
.U.
S. P
osta
gePA
IDPi
ttsbu
rgh,
PA
Perm
it No
. 383
4
Ele
ven
th I
nte
rnat
ion
al S
ympo
siu
m o
n
Reg
ion
al C
ance
r T
hera
pies
Sher
aton
Wil
d H
orse
Pas
s R
esor
t &
Spa
– C
han
dler
, Ari
zon
a
Fe
br
ua
ry
13
–1
5,
20
16
~ 2 ~ ~ 3 ~
Intent and Overview
This course is designed to cover the most recent advances in cancer therapy that are
primarily of a regional focus, such as gastrointestinal, intraperitoneal, hepatic, ovarian
and thoracic. Upon completion of the activity, learners from several disciplines should
be able to discuss the latest regional therapies in surgical oncology.
Who Should Attend
This course is designed for physicians and nurses practicing in the areas of Medical,
Surgical, Thoracic and Gynecologic Oncology and Gastroenterology.
Continuing Education Credit
The University of Pittsburgh School of Medicine is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical education
for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a
maximum of 20.75 AMA PRA Category 1 Credits™. Physicians should claim only the
credit commensurate with the extent of their participation in the activity.
Other health care professionals are awarded 2.0 continuing education units (CEU’s)
which are equal to 20.7 contact hours.
Special Needs
Participation by all individuals is encouraged. Advance notification of any special needs
will help us provide better service. Please notify us of your needs at least two weeks in
advance of the program by calling Maureen Hewko at (412) 623-5993.
We Gratefully Acknowledge Support from:
Magee-Womens Research Institute & Foundation
Schedule – Saturday, February 13, 2016
6:30 am Registration and Breakfast
6:45 am Welcome
Moderators: Steven Ahrendt, MD and Guillermo Flores Ayala, MD
7:00 am The Comprehensive Complication Index: A New Measure
of the Burden of Complications after HIPEC
Sinziana Dumitra, MD, et. al.
7:15 am Re-admissions for Delayed Complications after CRS and HIPEC
Vassiliki Manou, MD, et. al.
7:30 am Goal-Directed Fluid Management Improves Morbidity Associated with
Extended Cytoreduction and HIPEC
Laura Lambert, MD, et. al.
7:45 am Repeat CRS and HIPEC for the Treatment of Recurrent Peritoneal Surface
Malignancy: Is it Worthwhile?
Ramy Fouad, MD, et. al.
8:00 am Delayed Gastric Emptying following CRS and HIPEC
Lola Chabtini, MD, et. al.
8:15 am Acute Kidney Injury in Patients Undergoing CRS plus HIPEC
George Salti, MD, et. al.
8:30 am Impact of Previous Gynecologic Surgical Procedures on Short Term and
Oncological Outcomes in Patients Treated with CRS and HIPEC
Marcello Guaglio, MD, et. al.
8:45 am Is Diverting Ostomy Needed in High-Risk Anastomosis During
Cytoreductive Surgery and HIPEC?
Matthew Whealon, MD, et. al.
9:00 am Impact of Chemotherapy Regimen on Post-Operative Complications
After CRS and HIPEC
Juan Camilo Correa, MD, et. al.
9:15 am Debate: Repeat CRS/HIPEC for Patients Who Recur within Two Years?
Moderator: John Kane III, MD
YES — Kiran Turaga, MD NO — Konstantinos Votanopoulos, MD
9:45 am Break
~ 4 ~ ~ 5 ~
Moderators: T. Clark Gamblin, MD, MS and James Cusack, MD
10:00 am Does Fellowship Training Overcome the Learning Curve in Cytoreductive
Surgery and Heated Intraperitoneal Chemoperfusion
Cameron Schlegel, MD, et. al.
10:15 am Defining Selection Criteria for Patients with Advanced Peritoneal Carcinomatosis of Colorectal Origin
C. Komen Brown, MD, et. al.
10:30 am Impact of Body Mass Index (BMI) on Morbidity and Mortality in
Cytoreductive Surgery (CRS) with Intraperitoneal Chemotherapy (IPC)
Giorgos Karakousis, MD, et. al.
10:45 am Hepatic Artery Infusion for Recurrent or Chemo Resistant
Hepatic Malignancy
Harold Wanebo, MD, et. al.
11:00 am Novel Mouse Models of Hepatic Artery Infusion (HAI)
Minhyung Kim, MD, et. al.
11:15 am Overall Survival after Ablation for Small Size Hepatocellular Carcinoma
at Academic Cancer Centers vs. Community Cancer Centers
Nicholas Berger, MD, et. al.
11:30 am Ablation for Small HCC Lesions: Is Chemotherapy Necessary?
Nicholas Berger, MD, et. al.
11:45 am Liver Resection Following Selective Internal Radiation Treatment with
Yttrium-90: A Bi-Institutional Analysis
G. Paul Wright, MD, et. al.
Noon GUEST LECTURER
Hepatic Artery Infusional Chemotherapy for Primary and
Metastatic Cancer
Michael D’Angelica, MD, FACS
12:30 pm Break for Lunch
12:45 pm CASE PRESENTATION AND DISCUSSION
Discussants: H. Richard Alexander, MD and Nathan Bahary, MD
Immunotherapy for Peritoneal Carcinomatosis
Nathan Bahary, MD
Hepatoid Carcinoma of the Ovary with Peritoneal Metastases Treated
with Cytoreductive Surgery and HIPEC
Samer Naffouje, MD, et. al.
Unusual Presentation of Pseudomyxoma Peritonei
Amy Schulze, MD, et. al.
Intrauterine Metastases of Appendiceal Tumors Impact Cytoreduction
Jessica Cintolo-Gonzalez, MD, et. al.
Cytoreductive Surgery and HIPEC for Sarcomatosis from Uterine
Presentation of Gabriella Graham Patient Advocate Award
by Laura Lambert, MD
Schedule – Sunday, February 14, 2016 6:30 am Registration and Breakfast 6:45 am Welcome
Moderators: Jason Foster, MD and Matthew Holtzman, MD
7:00 am Recurrence of Malignant Peritoneal Mesothelioma:
Insights Based on Standardized Second Look Procedures
Michael Kluger, MD, et. al.
~ 6 ~ ~ 7 ~
7:15 am Peritoneal Surface Oncology Group International Registry on Peritoneal Mesothelioma
Marcello Deraco, MD, et. al. 7:30 am Outcomes of Well-Differentiated Papillary Peritoneal Mesothelioma Garrett Nash, MD, et. al. 7:45 am Nomogram to Predict Overall Survival in Diffuse Malignant Peritoneal
Mesothelioma: A Peritoneal Surface Oncology Group International (PSOGI) Multicenter Study
Shigeki Kusamura, MD, et. al. 8:00 am Long-term Combined Intraperitoneal and Systemic Chemotherapy for
Patients with Malignant Mesothelioma Results in Improved Survival Paul Sugarbaker, MD, et. al. 8:15 am Dual Cavity Malignant Mesothelioma: Presentation and Survival Yaakov Bressler, MD, et. al. 8:30 am Analysis of Outcomes in Young Patients (≤ 50 y) with Malignant
Peritoneal Mesothelioma Treated with Cytoreductive Surgery and HIPEC Julie Terhune, MD, et. al.
8:45 am Predicting Risk of Peritoneal Recurrence in Stage II Colon Cancer: Secondary Analysis of CALGB9581 Trial
Rahul Rajeev, MD, et. al. 9:00 am Multimodality Therapy for Peritoneal Metastases from Epithelial
Ovarian Cancer Deepa Magge, MD, et. al.
9:15 am GUEST LECTURER
Scientific Basis for CRS and HIPEC in the Treatment of Peritoneal Metastases: A Historical Perspective
Paul Sugarbaker, MD
9:45 am Break/Exhibitors/Posters Moderators: Robert Edwards, MD and Marcello Deraco, MD
10:00 am Perioperative Systemic Chemotherapy for Peritoneal Mucinous
Appendiceal Carcinomas Treated with Cytoreductive Surgery and HIPEC
John Spiliotis, MD, et. al.
10:15 am Multi-institution Review of the Role of Cytoreductive Surgery
and Heated Intraperitoneal Chemotherapy in Metastatic Gastric
Adenocarcinoma in the U.S.
Laura Enomoto, MD, et. al.
10:30 am Management of Peritoneal Carcinomatosis of a Colonic Origin: Role of
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy:
A Single Institution’s Experience over Two Decades
Chukwuemeka Ihemelandu, MD, et. al.
10:45 am Cytoreductive Surgery and HIPEC: Can We Improve Survival with Less
Postoperative Complications?
Mecker Moller, MD, et. al.
11:00 am Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Metastases
Combined with Curative Surgery for Hematogenous Metastases:
Analysis of Early and Long-Term Outcomes
Dario Baratti, MD, et. al.
11:15 am Peritonectomy Procedures Combined with HIPEC in Advanced Ovarian
Cancer Retrospective Italian National Multicenter Observational Study:
Update of 503 Cases
Paolo Sammartino, MD, et. al.
11:30 am Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors
with Peritoneal Dissemination After HIPEC
Joel Baumgartner, MD, et. al.
11:45 am Cytoreductive Surgery and HIPEC in the Management of Uterine
Sarcoma (US) with Peritoneal Dissemination (PD)
Armando Sardi, MD, et. al.
Noon GUEST LECTURER
New Advances in the Immunotherapy of Ovarian Cancer
Adekunle Odunsi, MD, PhD
12:30 pm Lunch
~ 8 ~ ~ 9 ~
1:00 pm PROPOSED AND ONGOING CLINICAL TRIALS
Discussants: Charles Staley, MD and Jesus Esquivel, MD
Assessment of Pre-Operative PCI Scoring with Integrated PET-DWI-MRI in Patients with Peritoneal Carcinomatosis: A Feasibility Pilot Study in Development
Daniel Labow, MD, et. al.
A Minimally Invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy
Kaitlyn Kelly, MD, et. al.
A Phase I Clinical Trial of Bi-Directional Chemotherapy for Unresectable Appendiceal or Colon Cancer
Bradley Switzer, MD, et. al.
A Phase II Study to Evaluate Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma with Peritoneal Carcinomatosis
Joel Baumgartner, MD, et. al.
The Role of Second-Look Laparoscopy in Patients at Risk of Recurrent Peritoneal Carcinomatosis
Yahel Agmon, MD, et. al.
Phase I/II Trial Evaluating aDCI Vaccines Combined with Tumor-selective Chemokine Modulation as Adjuvant Therapy after Surgical Resection of Peritoneal Surface Malignancies
Mark Girgis, MD
Update on ICARUS: A Randomized Trial of Intraperitoneal Chemotherapy After CRS for Appendiceal or Colorectal Carcinoma
Garrett Nash, MD
Prospective Randomized Trial Comparing Mitomycin and Oxaliplatinum in the Perfusate of Patients Undergoing HIPEC for Cancer of Appendix
Edward Levine, MD
2:00 pm Sunday Session Adjournment 6:00 pm Poster Viewing 7:00 pm ASPSM Meeting Schedule – Monday, February 15, 2016 6:30 am Registration and Breakfast 6:45 am Welcome
Moderators: Jonathan Zager, MD and Douglas Tyler, MD
7:00 am Pulmonary Suffusion for Oligometastatic Malignancies Todd Demmy, MD, et. al. 7:15 am BrachyVAC Treatment of Superficial Malignancies: Results of a
Consecutive Case Series Mark Goodman, MD, et. al. 7:30 am Clinical Response and Regional Toxicity Following Isolated Limb Infusion
Compared to Isolated Limb Perfusion for In-Transit Melanoma Metastases Lesly Dossett, MD, et. al. 7:45 am Electrochemotherapy in Locally Advanced Melanoma and Non-
Melanoma Skin Cancer: Experience from a Single Institution Alessandro Testori, MD, et. al. 8:00 am Inflammation-based Prognostic Scores; Utility in Prognostication and
Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with PC of a Colonic Origin
Chukwumeka Ihemelandu, MD, et. al. 8:15 am Aminolevulinic acid (ALA) is a Promising Compound for Detection of
Small Peritoneal Metastases: ALA Guided Cytoreductive Surgery Yutaka Yonemura, MD, et. al. 8:30 am A Comparison of Appendectomy Only vs. Cytoreductive Surgery and
HIPEC in 59 Patients with Early Stage Mucinous Appendiceal Neoplasms Jesus Esquivel, MD 8:45 am A Comprehensive Evaluation of Barriers to Referral of Patients for
Cytoreductive/HIPEC Valerie Francescutti, MD, et. al. 9:00 am A Snapshot of CS/HIPEC Perioperative Care Practice Patterns Around
the World: On the Pathway to Success or Opportunity for Improvement Allison Maciver, MD, et. al. 9:15 am Prognostic Factors and Significance of Gastrointestinal Leak
after Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC)
Konstantinos Chouliaras, MD, et. al. 9:30 am GUEST LECTURER
The Genetics of Peritoneal Surface Malignancies: Insights and Opportunities
Andrew Lowy, MD
10:00 am Break/Exhibitors/Posters
~ 10 ~ ~ 11 ~
Moderators: James Pingpank, MD and Brian Loggie, MD
10:15 am Multimodality Approach to Peritoneal Metastases: 1312 Patients Treated by a Multi-Disciplinary Team
Haroon Choudry, MD, et. al. 10:30 am Molecular Profiling: Prognostic Biomarkers in Patients Presenting with
Peritoneal Carcinomatosis of the Appendix and Colon Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
Chukwuemeka Ihemelanda, MD, et. al. 10:45 am Single-Port Access for Pressurized Intra-Peritoneal Aerosol
Chemotherapy (PIPAC): Feasibility and Safety Michele DeSimone, MD, et. al. 11:00 am MDM-2 Overexpression in Human Stem-like and Mature Colon
Cancer Cells as a Target for Anti-Cancer Therapy: Steps Toward a Translational Model
Mohammad Shaikh, MD, et. al. 11:15 am The Use of a pH-activated Indocyanine Green-Encoded Nanosensor
(PINS) for Detection of Peritoneal Disease Glen Balch, MD, et. al. 11:30 am Evaluation of Glycoprotein Expression Profiles in Peritoneal Metastases Asish Patel, MD, et. al. 11:45 am Exploration of Mutations in GI Cancers with Peritoneal Metastasis Asish Patel, MD, et. al. Noon Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System
for Cytoreductive Surgery Carlos HF Chan, MD, et. al. 12:15 pm Molecular Profiling of Appendix-Derived Pseudomyoxoma Peritonei (PMP) Elizabeth Gleeson, MD, et. al. 12:30 pm Analysis of Twenty Years of Reporting on Hyperthermic Intraperitoneal
Chemotherapy for Colorectal Cancers: Proposal for Standardized Reporting Samer Naffouje, MD, et. al. 12:45 pm Break for Lunch
12:55 pm Announcement and Presentation of Poster Award Winners 1:00 pm Conference Adjournment
Poster Presentations
1. The Effect of Perfusate Buffering on Toxicity and Response in Isolated Hepatic
Perfusion for Uveal Melanoma Metastases – Ilan Ben-Shabat, MD, et. al.
2. The Potential Impact of Host Murine Granulocytes on Growth of Human
Appendiceal Cancer – Laura Lambert, MD, et. al.
3. Expression of Adhesion Molecules in Peritoneal Carcinomatosis from Colon
Cancer: Identification of New Prognostic Factors – Simone Sibio, MD, et. al.
4. A Novel Approach to Diaphragm Resection in Cytoreductive Surgery – Cameron
Schlegel, MD, et. al.
5. A Phase II Randomized Study: Outcomes after Cytoreductive Surgery (CRS) with or
without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) followed
by Adjuvant Chemotherapy as Initial Treatment – Armando Sardi, MD, et. al.
6. BRAF Status as a Predictive Factor for Response in Isolated Limb Perfusion – Ilan
Ben-Shabat, MD, et. al.
7. Intensive Care Unit Hospitalization after Cytoreductive Surgery and Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) – John Spiliotis, MD, et. al.
8. Creating a Primary Regional Referral Center for Cytoreductive Surgery and Hyper
18. Trends in Utilization of CRS and HIPEC for Peritoneal Malignancies –
Kazi Ullah, MD, et. al.
19. Clinicopathological Features of Appendix Mucocele: Are We Too Aggressive? –
William Morano, MD, et. al.
20. Let’s Agree to Agree: Unification of Practice Among HighVolume CS/HIPEC
Surgeons in the United States – Eisar Al-Sukhni, MD, et. al.
21. Regional Therapy for Isolated Peritoneal Metastases from Small Bowel
and Upper Gastrointestinal Malignancies – Deepa Magge, MD, et. al.
22. Same Day Extubation After Cytoreductive Surgery and HIPEC –
Hatem Halabi, MD, et. al.
Course Co-Directors
H. Richard Alexander, MDProfessor of Surgery
University of Maryland School of Medicine
Baltimore, MD
David L. Bartlett, MDProfessor of Surgery
University of Pittsburgh School of Medicine
Robert P. Edwards, MDProfessor, Obstetrics, Gynecology and
Reproductive Sciences
University of Pittsburgh School of Medicine
T. Clark Gamblin, MD, MSStuart D. Wilson Chair in Surgical Oncology
Chief, Division of Surgical Oncology
Associate Professor of Surgery
Medical College of Wisconsin
Milwaukee, WI
Guest Faculty
Michael D’Angelica, MD, FACSEnid A. Haupt Chair in Surgery, Memorial
Sloan Kettering Cancer Center
Attending Surgeon, Hepatopancreatobiliary
Service, Memorial Sloan Kettering
Cancer Center
Program Director, Complex Surgical
Oncology and HPB Fellowship
Professor of Surgery, Cornell University,
Weill Medical College
New York, NY
Andrew Lowy, MDProfessor of Surgery
UC San Diego Medical Center
School of Medicine
La Jolla, CA
Adekunle Odunsi, MD, PhDCancer Center Deputy Director
The M. Steven Piver Professor and Chair
Department of Gynecologic Oncology
Executive Director, Center for
Immunotherapy
Roswell Park Cancer Institute
New York, NY
Paul H. Sugarbaker, MDDirector, Program in Peritoneal Surface
Malignancy
Washington Hospital Centre
Washington, DC
Invited Faculty
Steven Ahrendt, MDAssociate Professor of Surgery
University of Pittsburgh School of Medicine
Guillermo Flores Ayala, MD Instituto Jaliscience de Cancerologia
Guadalajara, Mexico
Nathan Bahary, MDAssociate Professor of Medicine
University of Pittsburgh School of Medicine
Glen Balch, MDAssistant Professor of Surgery
University of Texas
Dallas, TX
Joel Baumgartner, MDUCSD Moores Cancer Center
La Jolla, CA
C. Komen Brown, MDCancer Treatment Centers of America
Zion, IL
Haroon Choudry, MDAssistant Professor of Surgery
University of Pittsburgh School of Medicine
~ 14 ~ ~ 15 ~
James Cusack, MDAssociate Professor of Surgery
Harvard Medical School
Boston, MA
Marcello Deraco, MDSurgical Oncologist
Foundazione IRCCS Instituto
Nazionale dei Tumori
Milano, Italy
Jesus Esquivel, MDMedical Director, International
Oncology Initiatives
CTCA
Philadelphia, PA
Jason Foster, MDAssociate Professor of Surgery
Nebraska Medical Center
Omaha, NE
Matthew Holtzman, MDAssociate Professor of Surgery
University of Pittsburgh School of Medicine
John Kane III, MDAssociate Professor of Oncology
Roswell Park Cancer Institute
Associate Professor of Surgery
University of Buffalo
Buffalo, NY
Daniel Labow, MDThe Mount Sinai Medical Center
New York, NY
Laura Lambert, MDUniversity of Massachusetts
Medical School
Worcester, MA
Edward Levine, MDProfessor of Surgery
Wake Forest University
WinstonSalem, NC
Brian Loggie, MDProfessor of Surgery
Creighton University Medical Center
Omaha, NE
Garrett Nash, MDMemorial Sloan Kettering Cancer Center
New York, NY
James Pingpank, MDAssociate Professor of Surgery
University of Pittsburgh School of Medicine
Charles Staley, MDProfessor of Surgery
Emory University
Atlanta, GA
Kiran Turaga, MDAssistant Professor of Surgery
Medical College of Wisconsin
Milwaukee, WI
Douglas S. Tyler, MDProfessor of Surgery
Duke University
Durham, NC
Konstantinos Votanopoulos, MDAssociate Professor of Surgery
Wake Forest University
WinstonSalem, NC
Jonathan Zager, MDAssociate Professor of Surgery
Moffitt Cancer Center
Tampa, FL
All individuals in a position to control the content of this education activity are required to disclose all relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
Faculty reside in the Pittsburgh, Pennsylvania, metropolitan area unless indicated otherwise.
The University of Pittsburgh is an affirmative action, equal opportunity institution.
Abstract/Poster Presenters
Yahel Agmon, MDThe Mount Sinai Medical Center
New York, NY
Eisar Al-Sukhni, MDRoswell Park Cancer Institute
Buffalo, NY
Dario Baratti, MDInstituto Nazionale Tumori
Milano, Italy
Ilan Ben-Shabat, MDSahlgrenska University Hospital
Gothenburg, Sweden
Nicholas Berger, MDMedical College of Wisconsin
Milwaukee, WI
Yaakov Bressler, MDColumbia University Medical Center
New York, NY
David Brown, MDSwedish Cancer Institutte
Seattle, WA
Julie Campbell, MDPenn State Hershey College of Medicine
Hershey, PA
Lola Chabtini, MDIndiana University Department of Surgery
Indianapolis, IN
Carlos HF Chan, MDMassachusetts General Hospital
Boston, MA
Ea-sle Chang, MDSt. Louis University Hospital
St. Louis, MO
Konstantinos Chouliaras, MDWake Forest Baptist Health
WinstonSalem, NC
Jessica Cintolo-Gonzalez, MDMassachusetts General Hospital
Boston, MA
Juan Camilo Correa, MDUniversity of Toronto
Toronto, Canada
Todd Demmy, MDRutgers Cancer Institute of New Jersey
Visit the Center for Continuing Education in the Health Sciences Web Site
Our Internet address is: https://ccehs.upmc.com
The UPMC Center for Continuing Education in the Health Sciences invites you to visit our web location. Receive information on CME programs, earn CME credits on the Internet, and access information about our formal courses and much more. Discover who we are and how you can contact us. Please visit our web location often to get updated information on upcoming programs.